Back to the flow: a comprehensive systematic review and meta-analysis of epinephrine in the treatment of no-reflow
Therefore, intracoronary epinephrine was associated with encouraging but exploratory findings, and the higher success rate in primary no-reflow may reflect earlier intervention and less severe microvascular damage. Its modest advantage over adenosine suggests potential therapeutic value, though evidence remains limited and heterogeneous.
Authors
- F Ribeiro (ORCID: https://orcid.org/0009-0004-5081-2231)
- L. M. da SILVA
- Gabriel Rezende Neves (ORCID: https://orcid.org/0000-0001-5901-9935)
- Kalgi Modi (ORCID: https://orcid.org/0000-0001-8651-0826)
- Guilherme Sobreira Spina (ORCID: https://orcid.org/0000-0002-8876-0180)
- Pedro Antônio Machado Gomes de Sousa (ORCID: https://orcid.org/0009-0004-6842-2397)
- Leonardo Galvão de Oliveira Oldra
- P Antonio Machado Gomes De Sousa
- C Farias
- Eduarda Dexheimer da Silva
- Ricardo Fonseca Oliveira Suruagy-Motta
- Miguel Rodrigues Moreira
- Leonardo Cadorin de Araújo
- Kauã Gabriel Oliveira
Institutions
- Universidade de São Paulo (BR)
- Anhembi Morumbi University (BR)
- Universidade do Estado do Pará (BR)
- Louisiana State University in Shreveport (US)
- Universidade Nove de Julho (BR)
- Universidade Federal de Santa Maria (BR)
- Centro Universitário Cesmac (BR)
- Universidade Federal de Uberlândia (BR)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- Coronary Artery Disease
- Published
- 2026-03-23
- DOI
- https://doi.org/10.1097/mca.0000000000001632
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00